Provided by Tiger Trade Technology Pte. Ltd.

Commercial Metals

66.63
+1.762.71%
Volume:391.81K
Turnover:25.82M
Market Cap:7.40B
PE:12.66
High:66.69
Open:65.61
Low:64.60
Close:64.87
52wk High:84.87
52wk Low:53.08
Shares:111.05M
Float Shares:109.72M
Volume Ratio:0.40
T/O Rate:0.36%
Dividend:0.74
Dividend Rate:1.11%
EPS(TTM):5.26
EPS(LYR):0.7400
ROE:13.79%
ROA:6.32%
PB:1.63
PE(LYR):90.04

Loading ...

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

GlobeNewswire
·
May 14

Commercial Metals Co : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
May 14

Press Release: Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Dow Jones
·
May 14

UBS Upgrades Commercial Metals to Buy From Neutral, Adjusts Price Target to $89 From $79

MT Newswires Live
·
May 14

Commercial Metals Raised to Buy From Neutral by UBS

Dow Jones
·
May 14

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Reuters
·
May 14

Commercial Metals upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 14

Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

GlobeNewswire
·
May 13

CoinMarketCap warns users over fake CMC token scam

cryptonews
·
May 13

CMC Corp Sees FY Net Y2.20B

Dow Jones
·
May 13

Fake 'CMC Tokens' Trigger Crypto Scam Alert From CoinMarketCap

utoday
·
May 13

Press Release: Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates

Dow Jones
·
May 13

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

Press Release: Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 12

Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

Dow Jones
·
May 12

Table: CMC Magnetics Apr Rev NT$601.8M Vs NT$611.1M

Dow Jones
·
May 11

CMC Corp Sees 1H Parent Pretax Y2.00B

Dow Jones
·
May 07

CMC Markets Executives Acquire Shares Under UK Incentive Plan

TIPRANKS
·
May 06

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 06

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

GlobeNewswire
·
May 05